EP1585767 - SYNTHETIC ANTIBODY PHAGE LIBRARIES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 09.07.2010 Database last updated on 12.07.2024 | Most recent event Tooltip | 09.07.2010 | Application deemed to be withdrawn | published on 11.08.2010 [2010/32] | Applicant(s) | For all designated states Genentech, Inc. 1 DNA Way South San Francisco, CA 94080-4990 / US | [N/P] |
Former [2005/42] | For all designated states GENENTECH, INC. 1 DNA Way South San Francisco, CA 94080-4990 / US | Inventor(s) | 01 /
BOND, Christopher, J. 2868 22nd Street San Francisco, CA 94110 / US | [2005/42] | Representative(s) | Harding, Charles Thomas D Young & Co LLP 120 Holborn London EC1N 2DY / GB | [N/P] |
Former [2005/42] | Harding, Charles Thomas D Young & Co 120 Holborn London EC1N 2DY / GB | Application number, filing date | 04702925.1 | 16.01.2004 | [2005/42] | WO2004US01097 | Priority number, date | US20030441059P | 16.01.2003 Original published format: US 441059 P | US20030488610P | 18.07.2003 Original published format: US 488610 P | US20030510314P | 08.10.2003 Original published format: US 510314 P | [2005/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2004065416 | Date: | 05.08.2004 | Language: | EN | [2004/32] | Type: | A2 Application without search report | No.: | EP1585767 | Date: | 19.10.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.08.2004 takes the place of the publication of the European patent application. | [2005/42] | Search report(s) | International search report - published on: | EP | 10.02.2005 | Classification | IPC: | C07K16/00, C12N15/13, C12N15/85, C12N5/10 | [2005/42] | CPC: |
C07K16/005 (EP,US);
C07K2317/22 (EP,US);
C07K2317/54 (EP,US);
C07K2317/55 (EP,US);
C07K2317/56 (EP,US);
C07K2317/565 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/42] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | PHAGENBIBLIOTHEK VON SYNTHETISCHEN ANTIKÖRPERN | [2005/42] | English: | SYNTHETIC ANTIBODY PHAGE LIBRARIES | [2005/42] | French: | BANQUES DE PHAGES ANTICORPS SYNTHETIQUES | [2005/42] | Entry into regional phase | 10.08.2005 | National basic fee paid | 10.08.2005 | Designation fee(s) paid | 10.08.2005 | Examination fee paid | Examination procedure | 10.08.2005 | Examination requested [2005/42] | 02.11.2007 | Despatch of a communication from the examining division (Time limit: M06) | 09.05.2008 | Reply to a communication from the examining division | 12.10.2009 | Despatch of a communication from the examining division (Time limit: M04) | 23.02.2010 | Application deemed to be withdrawn, date of legal effect [2010/32] | 29.03.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2010/32] | Fees paid | Renewal fee | 12.01.2006 | Renewal fee patent year 03 | 12.01.2007 | Renewal fee patent year 04 | 14.01.2008 | Renewal fee patent year 05 | 14.01.2009 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.01.2010 | 07   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO0077194 (GENENTECH INC [US]) [X] 59,60,66-69,77-83,85-89,92-95,105,106,112-114 * page 9, line 22 - page 10, line 4 * * examples 4-6 * * claim - *; | [X]WO0024884 (UNILEVER PLC [GB], et al) [X] 105,112,114 * figure 2 *; | [A]WO0190190 (CA NAT RESEARCH COUNCIL [CA], et al) [A] 59-114 * claim - *; | [X] - TANHA J ET AL, "Optimal design features of camelized human single-domain antibody libraries", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, (20010706), vol. 276, no. 27, ISSN 0021-9258, pages 24774 - 24780, XP002283749 [X] 59-61,67,77-83,85-89 * tables II,III * * page 24779, column L, paragraph 3 * DOI: http://dx.doi.org/10.1074/jbc.M100770200 | [X] - ARBABI GHAHROUDI M ET AL, "Selection and identification of single domain antibody fragments from camel heavy-chain antibodies", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (19970915), vol. 414, no. 3, ISSN 0014-5793, pages 521 - 526, XP004261105 [X] 105,106,112-114 * page 521, column R, paragraph 3 * * page 522, column L, paragraphs 2,3 * * figure 2 * DOI: http://dx.doi.org/10.1016/S0014-5793(97)01062-4 | [X] - HARMSEN M M ET AL, "Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features", MOLECULAR IMMUNOLOGY, ELMSFORD, NY, US, (200008), vol. 37, no. 10, ISSN 0161-5890, pages 579 - 590, XP002244235 [X] 59,111 * fig.1 Accession number: AJ237368, 005523 * * page 587, column L, paragraph 3 - page 588, column R, paragraph 2 * DOI: http://dx.doi.org/10.1016/S0161-5890(00)00081-X | [A] - MUYLDERMANS S, "SINGLE DOMAIN CAMEL ANTIBODIES: CURRENT STATUS", REVIEWS IN MOLECULAR BIOTECHNOLOGY, ELSEVIER, AMSTERDAM,, NL, (200106), vol. 74, no. 4, ISSN 1389-0352, pages 277 - 302, XP001057480 [A] 59-114 * Section 2.5.3 * DOI: http://dx.doi.org/10.1016/S1389-0352(01)00021-6 | [A] - VAJDOS F F ET AL, "Comprehensive Functional Maps of the Antigen-binding Site of an Anti-ErbB2 Antibody Obtained with Shotgun Scanning Mutagenesis", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, (20020705), vol. 320, no. 2, ISSN 0022-2836, pages 415 - 428, XP004449739 [A] 59-114 * the whole document * DOI: http://dx.doi.org/10.1016/S0022-2836(02)00264-4 | [T] - BOND C J ET AL, "Contributions of CDR3 to VHH Domain Stability and the Design of Monobody Scaffolds for Naive Antibody Libraries", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, (20030919), vol. 332, no. 3, ISSN 0022-2836, pages 643 - 655, XP004454278 [T] 105,112,114 * page 644, column R, paragraph L - page 645, column L, paragraph 1 * DOI: http://dx.doi.org/10.1016/S0022-2836(03)00967-7 | [T] - SIDHU S S ET AL, "Phage-displayed Antibody Libraries of Synthetic Heavy Chain Complementarity Determining Regions", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, (20040423), vol. 338, no. 2, ISSN 0022-2836, pages 299 - 310, XP004500301 [T] 59-114 * the whole document * DOI: http://dx.doi.org/10.1016/j.jmb.2004.02.050 | [T] - PRESTA L G ET AL, "HUMANIZATION OF AN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOCLONAL ANTIBODY FOR THE THERAPY OF SOLID TUMORS AND OTHER DISORDERS", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, (19971015), vol. 57, ISSN 0008-5472, pages 4593 - 4599, XP002926854 [T] 59-114 * the whole document * | Examination | - KRUIF DE J. ET AL, "SELECTION AND APPLICATION OF HUMAN SINGLE CHAIN FV ANTIBODY FRAGMENTS FROM A SEMI-SYNTHETIC PHAGE ANTIBODY DISPLEY LIBRARY WITHDESIGNED CDR3 REGIONS", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, (19950421), vol. 248, no. 1, pages 97 - 105, XP000646544 DOI: http://dx.doi.org/10.1006/jmbi.1995.0204 |